EXPERIMENTAL STUDIES
Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism
Paul F. Kantor, MBBCh*,
Murray A. Robertson, MD, PhD ,
James Y. Coe, MD, MBChB and
Gary D. Lopaschuk, PhD*
* Cardiovascular Research Group, University of Alberta, Edmonton, Canada
Division of Pediatric Cardiology, University of Alberta, Edmonton, Canada
Manuscript received April 6, 1998;
revised manuscript received December 3, 1998,
accepted January 21, 1999.
Reprint requests and correspondence: Dr. Paul F. Kantor, 423 Heritage Medical Research Center, University of Alberta, Edmonton, T6G 2S2 Canada
pkantor{at}gpu.srv.ualberta.ca
OBJECTIVES
The purpose of this study was to determine the effect of volume overload hypertrophy in the newborn heart on the cardiac enzymes controlling fatty acid metabolism.
BACKGROUND
Shortly after birth, a rise in 5'-adenosine monophosphate–activated protein kinase (AMPK) activity results in the phosphorylation and inhibition of acetyl coenzyme A (CoA) carboxylase (ACC), and a decline in myocardial malonyl CoA levels with increased fatty acid oxidation rates. Whether the early onset of hypertrophy in the newborn heart alters this maturational increase in fatty acid oxidation is unknown.
METHODS
Newborn piglets underwent endovascular stenting of the ductus arteriosus on day 1 of life with a 4.5-mm diameter stent, resulting in a left to right shunt, and left ventricular (LV) volume loading. Left ventricular and right ventricular samples from fetal, newborn, threeweek control and three-week stented animals were compared.
RESULTS
Stenting resulted in echocardiographic evidence of volume overload and myocardial hypertrophy. In control animals, left ventricular ACC activity declined from 274 ± 30 pmol/mg/min on day 1 to 115 ± 12 after three weeks (p < 0.05), but did not display this maturation drop in hypertrophied hearts, remaining elevated (270 ± 50 pmol/mg/min, p < 0.05). At three weeks, malonyl CoA levels remained 2.8-fold higher in hypertrophied hearts than in control hearts. In control hearts, LV AMPK activity increased 178% between day 1 and three weeks, whereas in hypertrophied hearts AMPK activity at three weeks was only 71% of control values, due to a significant decrease in expression of the catalytic subunit of AMPK.
CONCLUSIONS
Early onset LV volume overload with hypertrophy results in a delay in the normal maturation of fatty acid oxidation in the newborn heart.
|
Abbreviations and Acronyms
| | ACC | = acetyl coenzyme A carboxylase | | AMP | = adenosine monophosphate | | AMPK | = 5' adenosine monophosphate–activated protein kinase | | CoA | = coenzyme A | | LV | = left ventricular | | PEG | = polyethylene glycol | | RV | = right ventricular |
|
This article has been cited by other articles:
|
|
|
|
 
M. van Bilsen, F. A. van Nieuwenhoven, and G. J. van der Vusse
Metabolic remodelling of the failing heart: beneficial or detrimental?
Cardiovasc Res,
February 15, 2009;
81(3):
420 - 428.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. J. Chess, B. Lei, B. D. Hoit, A. M. Azimzadeh, and W. C. Stanley
Deleterious effects of sugar and protective effects of starch on cardiac remodeling, contractile dysfunction, and mortality in response to pressure overload
Am J Physiol Heart Circ Physiol,
September 1, 2007;
293(3):
H1853 - H1860.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Liao, S. Takashima, N. Maeda, N. Ouchi, K. Komamura, I. Shimomura, M. Hori, Y. Matsuzawa, T. Funahashi, and M. Kitakaze
Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism
Cardiovasc Res,
September 1, 2005;
67(4):
705 - 713.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk
Myocardial Substrate Metabolism in the Normal and Failing Heart
Physiol Rev,
July 1, 2005;
85(3):
1093 - 1129.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Thomson and S. E. Gordon
Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation
J Appl Physiol,
February 1, 2005;
98(2):
557 - 564.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Tanaka, T. Kono, F. Terasaki, T. Kintaka, K. Sohmiya, T. Mishima, and Y. Kitaura
Gene-environment interactions in wet beriberi: effects of thiamine depletion in CD36-defect rats
Am J Physiol Heart Circ Physiol,
October 1, 2003;
285(4):
H1546 - H1553.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. O. Besikci, F. M. Campbell, T. A. Hopkins, J. R. B. Dyck, and G. D. Lopaschuk
Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart
Am J Physiol Heart Circ Physiol,
January 1, 2003;
284(1):
H283 - H289.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. de las Fuentes, P. Herrero, L. R. Peterson, D. P. Kelly, R. J. Gropler, and V. G. Davila-Roman
Myocardial Fatty Acid Metabolism: Independent Predictor of Left Ventricular Mass in Hypertensive Heart Disease
Hypertension,
January 1, 2003;
41(1):
83 - 87.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V.i. G. Davila-Roman, G. Vedala, P. Herrero, L. de las Fuentes, J. G. Rogers, D. P. Kelly, and R. J. Gropler
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
J. Am. Coll. Cardiol.,
July 17, 2002;
40(2):
271 - 277.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Young, G. W. Goodwin, J. Ying, P. Guthrie, C. R. Wilson, F. A. Laws, and H. Taegtmeyer
Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids
Am J Physiol Endocrinol Metab,
March 1, 2001;
280(3):
E471 - E479.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
